Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.5.0. The update appears to be a platform version bump with no changes to the trial details or essential content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedDocument revision updated from v3.4.1 to v3.4.2 for study-related materials.SummaryDifference0.0%

- Check57 days agoChange DetectedPage revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check64 days agoChange DetectedUI text updates include a 'Show glossary' label and capitalization adjustments for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new page revision tag 'Revision: v3.4.0' replacing the previous 'v3.3.4'.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.